Recommending Randomized Trials for Pediatric Leukemia: Observer and Physician Report of Recommendations

Abstract

Physicians' presentation of treatment options in a non-coercive manner is critical for informed consent for participation in randomized clinical trials (RCTs). This study examined discrepancies between observer and physician report of treatment recommendations for pediatric leukemia RCTs. This study also assessed relationships between recommendations and decisions to participate in RCTs. Participants were 104 parents of children with leukemia and the treating physicians. Measures included observations of informed consent conferences (ICCs), physician report of treatment recommendations, and parent report of trial participation. Observation revealed that physicians recommended RCTs in 38% of ICCs, while physicians reported recommending RCTs in 73% of ICCs. Treatment recommendations were unrelated to decisions to participate in RCTs. Results highlight the importance of enhancing parent-physician communication regarding RCT participation.

Keywords

treatment recommendation informed consent pediatric leukemia

Get full access to this article

View all access options for this article.

References

Brown

R.F.

Butow

P.N.

Ellis

Boyle

, & Tattersall

M.H.N.

(2004). Seeking informed consent to cancer clinical trials: Describing current practice. Social Sciences and Medicine, 58, 2445–2457.

Curlin

F.A.

Lawrence

R.E.

Chin

M.H.

, & Lantos

J.D.

(2007). Religion, conscience, and controversial clinical practice. The New England Journal of Medicine, 356, 593–600.

Eder

(2006). Parental decision making about children's participation in clinical research. Unpublished doctoral dissertation. Case Western Reserve University, Cleveland, OH.

Hazen

R.A.

Drotar

, & Kodish

(2006). The role of the consent document in informed consent for pediatric leukemia trials. Contemporary Clinical Trials. doi: 10.1016/j.cct.2006.10.011.

Hollingshead

(1957). Two Factor Index of Social Position. New Haven, Conn: Yale University.

Kodish

Eder

Noll

R.B.

Ruccione

Lange

Angiolillo

(2004). Communication of randomization in childhood leukemia trials. Journal of the American Medical Association, 291, 470–475.

Lenrow

D.A.

& Chou

L.H.

(2002). Interventional spine research: The evolution of informed consent. Pain Physician, 5, 8–17.

Miller

V.A.

, [removed from review], Burant, C., & [removed from review]. (2005) Clinician-Parent communication during informed consent for pediatric leukemia trials. Journal of Pediatric Psychology, 30, 219–229.

Pui

(1999). Childhood Leukemias. Cambridge, England: Cambridge University Press.

10.

Reaman

G.H.

(2003). Children's Oncology Group Statement on Research Involving Children. Retrieved March 6, 2007, from http://www.iom.edu/CMS/3740/4864/13662/13665/14423.aspx.

11.

Siminoff

L.A.

& Fetting

(1991). Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer. Social Sciences and Medicine, 32, 813–818.

12.

Simon

Eder

Raiz

Zyzanski

Pentz

, & Kodish

(2001). Informed consent for pediatric leukemia research: Clinician perspective. Cancer, 92, 691–700.

13.

Wager

Tooley

P.J.H.

Emanuel

M.B.

, & Wood

S.F.

(1995). How to do it: Get patients' consent to enter clinical trials. British Medical Journal, 333, 734–737.